Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin-Yu Perera

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Microbes and Infection|May 22, 2021
Development of leading first-generation vaccines against SARS-CoV-2Pin-Yu Perera, Liyanage P Perera
Vaccines|February 26, 2022
Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and ChallengesVictor E Nava, Pin-Yu Perera, Nirbhay Kumar, et al.
Microbes and Infection|November 9, 2011
The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic usePin-Yu Perera, Jack H Lichy, Thomas A Waldmann, et al.
Journal of Clinical Immunology|December 28, 2012
Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac diseaseSeiji Yokoyama, Pin-Yu Perera, Thomas A Waldmann, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 5, 2008
Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonistPin-Yu Perera, Jack H Lichy, John Mastropaolo, et al.
World Journal of Oncology|February 26, 2020
Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma DiagnosisPin-Yu Perera, Liyanage P Perera, Lyvouch Filkoski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling eventsNilofer Qureshi, Pin-Yu Perera, Jing Shen, et al.
Journal of Clinical Immunology|October 11, 2015
Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)Seiji Yokoyama, Pin-Yu Perera, Seigo Terawaki, et al.
Vaccine|August 24, 2010
Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeysRafal J Zielinski, Jeremy V Smedley, Pin-Yu Perera, et al.
American Journal of Hematology|May 26, 2017
Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignanciesLiyanage P Perera, Meili Zhang, Masao Nakagawa, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Microbes and Infection|May 22, 2021
Development of leading first-generation vaccines against SARS-CoV-2Pin-Yu Perera, Liyanage P Perera
Vaccines|February 26, 2022
Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and ChallengesVictor E Nava, Pin-Yu Perera, Nirbhay Kumar, et al.
Microbes and Infection|November 9, 2011
The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic usePin-Yu Perera, Jack H Lichy, Thomas A Waldmann, et al.
Journal of Clinical Immunology|December 28, 2012
Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac diseaseSeiji Yokoyama, Pin-Yu Perera, Thomas A Waldmann, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 5, 2008
Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonistPin-Yu Perera, Jack H Lichy, John Mastropaolo, et al.
World Journal of Oncology|February 26, 2020
Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma DiagnosisPin-Yu Perera, Liyanage P Perera, Lyvouch Filkoski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling eventsNilofer Qureshi, Pin-Yu Perera, Jing Shen, et al.
Journal of Clinical Immunology|October 11, 2015
Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)Seiji Yokoyama, Pin-Yu Perera, Seigo Terawaki, et al.
Vaccine|August 24, 2010
Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeysRafal J Zielinski, Jeremy V Smedley, Pin-Yu Perera, et al.
American Journal of Hematology|May 26, 2017
Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignanciesLiyanage P Perera, Meili Zhang, Masao Nakagawa, et al.
Pageof 2